NONOF News and Press, Novo-Nordisk A/S From 09/03/23

2023-09-03 12:00:00 ET More on Medicare pricing negotiations Wall Street lists potential targets for Medicare drug price negotiations Analysts rule out major industry impact from drug pricing negotiations J&J, Merck, Regeneron most exposed to Medicare drug price ...

2023-09-01 07:54:49 ET More on Novo Nordisk Novo Nordisk: Super Focused Pharma Company For The Long Run Novo Nordisk: Strong Fundamentals Meet Technical Uptrends Eli Lilly And Novo Nordisk: Are Weight Loss Drugs A Global Revolution Or Short-Lived Fad? Novo No...

2023-08-31 11:17:22 ET Summary Novo Nordisk is a high-quality pharmaceutical company with a unique ownership structure, controlled by a charitable foundation. The company specializes in diabetes and obesity treatments, with a focus on insulin and GLP-1 analogues. Despite a tem...

2023-08-30 09:48:11 ET More on Novo Nordisk Novo Nordisk: Market Leader In A Growing Market Novo Nordisk: High Valuation Reflects Promising Outlook In Obesity Care Novo Nordisk: Denmark's Coca-Cola The Case For Novo Nordisk: Growth, Dividends, And A New Treat...

2023-08-29 07:45:20 ET The Centers for Medicare and Medicaid Services (CMS) announced on Tuesday the first 10 Medicare Part D drugs it selected for pricing negotiations, a provision introduced as part of last year's Inflation Reduction Act. The list includes Eliquis , a blood thinne...

2023-08-23 09:00:14 ET More on Novo, Thermo, etc. Thermo Fisher: Cash Flow Returns On Investments Analysis Novo Nordisk A/S 2023 Q2 - Results - Earnings Call Presentation Novo Nordisk A/S ( NVO ) Q2 2023 Earnings Call Transcript Novo Nordisk: Market Leade...

2023-08-18 13:09:45 ET Summary On August 7, Viatris released its financial results for the 2nd quarter of 2023, which, after a long time, finally managed to beat analysts' expectations. Viatris' revenue for the second quarter of 2023 was $3.92 billion, up 5.1% from the previous qu...

2023-08-15 15:06:54 ET Billionaire investor Philippe Laffont's Coatue Management in Q2 2023 took news stakes in Eli Lilly ( NYSE: LLY ) and Oracle ( NYSE: ORCL ), exited GameStop ( NYSE: GME ) and Salesforce ( NYSE: CRM ), trimmed its positions in Tesla ...

2023-08-10 12:03:57 ET More on Novo Nordisk Novo Nordisk A/S ( NVO ) Q2 2023 Earnings Call Transcript Novo Nordisk: High Valuation Reflects Promising Outlook In Obesity Care Novo Nordisk: Denmark's Coca-Cola The Case For Novo Nordisk: Growth, Dividends, A...

2023-08-10 11:41:04 ET Novo Nordisk A/S (NVO) Q2 2023 Earnings Conference Call August 10, 2023, 07:00 ET Company Participants Daniel Bohsen - CVP & Head, IR Lars Jorgensen - President & CEO Camilla Sylvest - EVP, Commercial Strategy & Corporate Affair...